ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2017 041 953.2, EP file number: 18 19 3241.9 (Designation/title: PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT RIFAXIMIN ALPHA UND DELTA)

↩ Details

Tabular representation
Current state: Not active, Current state: Termination likely/termination

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Jan 30, 2019Jan 30, 2019 Filing
2 Q10 Document published Mar 14, 2019Mar 14, 2019Mar 14, 2019 Filing
3 Q10 Document published Jul 7, 2021Jul 7, 2021 Examination
4 Q10 Document published Jul 22, 2021Jul 22, 2021Jul 22, 2021 Examination
5 E10 Pre-grant review requested Mar 21, 2022Mar 21, 2022May 12, 2022 Pre-grant challenge
6 B10 Application discontinued Feb 1, 2024Feb 1, 2024Jul 11, 2024 Termination likely/termination
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Jan 30, 2019Jan 30, 2019 Filing
2 Q10 Document published Mar 14, 2019Mar 14, 2019Mar 14, 2019 Filing
3 Q10 Document published Jul 7, 2021Jul 7, 2021 Examination
4 Q10 Document published Jul 22, 2021Jul 22, 2021Jul 22, 2021 Examination
5 E11 Pre-grant opposition filed Mar 21, 2022Mar 21, 2022May 12, 2022 Pre-grant challenge
6 B17 Application discontinued following pre-grant review Feb 1, 2024Feb 1, 2024Jul 11, 2024 Termination likely/termination

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data